TLR4 and severe acute respiratory syndrome: Interestingly, while PTPN4 acts as an inhibitor, the TLR4 signaling pathway is activated by the SARS-CoV-2 spike protein [64], and mice lacking TLR4 had more severe SARS-CoV infections than wild-type mice [65].